MDMG — MD Medical Investments Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | 23.11% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.34% | ||
| Return on Equity | 18.39% | ||
| Operating Margin | 19.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | RUBm | 14,937.37 | 16,159.86 | 19,133.5 | 25,219.68 | 25,222.06 | 33,014 | 35,977 | 12.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.55 | -1.39 | +49.57 | +52.05 | -2.57 | +46.92 | +5.51 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MD Medical Group Investments Plc is an investment holding company. The Company is a provider of private healthcare for women and children. The Company's services include obstetrics and gynecology, pediatrics, fertility and in vitro fertilization (IVF) treatment, and other services, including laboratory services, stem cell storage, trauma, rehabilitation, dental care and surgery, among other services. The Company operates 23 medical centers across Russia, which includes four hospitals and 19 out-patient clinics in Moscow, Ryazan, Yaroslavl, St. Petersburg, Samara and Samara Region, Perm, Ufa, Novosibirsk and Irkutsk. It offers both in-patient care hospitals and out-patient care clinics. The Company owns its own laboratory, stem cell bank and ambulance service.
Directors
- Vladimir Mekler NEC
- Mark Kurtser CEO (63)
- Maria Nechaeva DCE
- Vadim Vlasov DCE
- Andrey Khoperskiy CFO
- Pavel Bogomolov DGD
- Sergey Arabadzhyan OTH
- Boris Konoplev OTH
- Yulia Kutakova OTH (47)
- Natalia Yakunina OTH
- Kirill Dmitriev NED (46)
- Vitaly Ustimenko NED (39)
- Tatiana Lukina NID
- Tony Maher NID (63)
- Simon Rowlands NID (63)
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- August 5th, 2010
- Public Since
- October 12th, 2012
- No. of Employees
- 8,466
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 75,125,010
- Address
- 2nd floor, office #7, NICOSIA, 2024
- Web
- Phone
- +357 22504000
- Auditors
- KPMG Ltd
Latest News for MDMG
Upcoming Events for MDMG
Q2 2023 MD Medical Group Investments PLC Operating Results
Half Year 2023 MD Medical Group Investments PLC Earnings Release
Q3 2023 MD Medical Group Investments PLC Operating Results
Similar to MDMG
Burning Rock Biotech
London Stock Exchange
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
IQ-AI
London Stock Exchange
FAQ
As of Today at 19:13 UTC, shares in MD Medical Investments are trading at $5.70. This share price information is delayed by 15 minutes.
Shares in MD Medical Investments last closed at $5.70 and the price had moved by -17.39% over the past 365 days. In terms of relative price strength the MD Medical Investments share price has underperformed the FTSE All Share Index by -18.99% over the past year.
The overall consensus recommendation for MD Medical Investments is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMD Medical Investments does not currently pay a dividend.
MD Medical Investments does not currently pay a dividend.
MD Medical Investments does not currently pay a dividend.
To buy shares in MD Medical Investments you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.70, shares in MD Medical Investments had a market capitalisation of .
Here are the trading details for MD Medical Investments:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MDMG
Based on an overall assessment of its quality, value and momentum MD Medical Investments is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MD Medical Investments. Over the past six months, its share price has underperformed the FTSE All Share Index by -52%.
As of the last closing price of $5.70, shares in MD Medical Investments were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The MD Medical Investments PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
MD Medical Investments' management team is headed by:
- Vladimir Mekler - NEC
- Mark Kurtser - CEO
- Maria Nechaeva - DCE
- Vadim Vlasov - DCE
- Andrey Khoperskiy - CFO
- Pavel Bogomolov - DGD
- Sergey Arabadzhyan - OTH
- Boris Konoplev - OTH
- Yulia Kutakova - OTH
- Natalia Yakunina - OTH
- Kirill Dmitriev - NED
- Vitaly Ustimenko - NED
- Tatiana Lukina - NID
- Tony Maher - NID
- Simon Rowlands - NID